Cy4gate (CY4) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
7 May, 2026Company overview and market positioning
Operates as a 360° cyber vendor with proprietary technology and solutions, serving governments, large corporations, and SMEs in cyber intelligence and cybersecurity markets.
Holds a unique position across all three major cyber market segments, offering tailor-made solutions and maintaining a global presence.
Growth driven by investments in talent, strategic partnerships, and M&A activity; listed on the STAR Market since June 2023.
Group structure includes full ownership of RCS, majority stakes in Diateam and XTX Cognitive Security, and a diversified shareholder base.
Product portfolio and addressable markets
Offers cyber intelligence, cyber security, and decision intelligence solutions, including platforms like QUIPO and services such as real-time analytics and forensic intelligence.
Global cyber intelligence and forensic intelligence markets are experiencing double-digit growth, with significant expansion projected through 2027.
Cybersecurity products and services markets are also growing steadily, with a focus on SIEM, SOAR, and managed detection and response.
Strategy and outlook
Targets fast-growing defence, law enforcement, and corporate markets, leveraging AI and decision intelligence for digital transformation.
Strategic actions include strengthening partnerships, expanding geographically, increasing market penetration, and pursuing M&A opportunities.
Aims to mitigate seasonality, consolidate leadership in Italy and the EU, and create recurring revenue streams.
Latest events from Cy4gate
- Strong growth in cyber intelligence and security, targeting €84–90M revenues in 2024.CY4
Investor presentation7 May 2026 - Cybersecurity and intelligence group pursues growth via innovation, M&A, and ESG leadership.CY4
Investor presentation7 May 2026 - Achieved 10% revenue growth in 2024, with strong defense sector and ESG commitments.CY4
Investor presentation7 May 2026 - H1 2025 saw 30% revenue growth, margin expansion, and strengthened ESG commitments.CY4
Investor presentation7 May 2026 - Strong 2025 growth in forensic and decision intelligence, with robust financial and ESG progress.CY4
Investor presentation7 May 2026 - Strong growth, improved margins, and robust backlog support a positive 2026 outlook.CY4
Q4 20257 May 2026 - Double-digit growth, record new orders, and improved EBITDA margin support 2025 guidance.CY4
Q1 20257 May 2026 - H1 2024 saw lower revenues and a wider net loss, but €84–90M FY 2024 guidance is confirmed.CY4
Q2 20247 May 2026 - Revenues and EBITDA rose, margin improved, but net financial debt increased.CY4
Q3 20247 May 2026